Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulphate vs Lidocaine for emergence hypertension after craniotomy
NCT03566329Phase 1Unknown
- Start
- Jul 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of magnesium sulfate and Lidocaine Hydrochloride Injection, without epinephrine in hypertension (HTN). Primary endpoint: postcraniotomy emergence hypertension response to the study drugs at 4 hours. Status: unknown.
02
Drugs
magnesium sulfateLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03566329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03566329.